NPM1 mutations, one of the most common genetic drivers of AML, are now actionable for patients –– Acute unmet need in R/R ...
Extending anti-clotting drugs beyond the initial treatment period of at least 90 days after a first blood clot is linked to ...
A 79-year-old man was admitted to a hospital in Guangzhou, China, with progressive dyspnea and edema. Echocardiography and ...
Disclaimer: This article is for educational purposes only and does not replace medical advice. If you are experiencing ...